Related references
Note: Only part of the references are listed.Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes
Shinji Inaba et al.
STROKE (2009)
Protective effects of angiotensin II Type I receptor blocker on cerebral circulation independent of blood pressure
Yasuhiro Kumai et al.
EXPERIMENTAL NEUROLOGY (2008)
Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition
Li-Juan Min et al.
HYPERTENSION (2008)
Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine
Kana Tsukuda et al.
HYPERTENSION (2008)
Candesartan and cognitive decline in older patients with hypertension - A substudy of the SCOPE trial
B. K. Saxby et al.
NEUROLOGY (2008)
Excess Salt Causes Cerebral Neuronal Apoptosis and Inflammation in Stroke-Prone Hypertensive Rats Through Angiotensin II-Induced NADPH Oxidase Activation
Eiichiro Yamamoto et al.
STROKE (2008)
Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density
Jian-Mei Li et al.
STROKE (2008)
Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension
Weiying Dai et al.
STROKE (2008)
Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan
Kana Tsukuda et al.
HYPERTENSION (2007)
Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain
Laibaik Park et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan
Masaki Mogi et al.
NEUROPHARMACOLOGY (2007)
NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat
Yongzhong Wei et al.
HYPERTENSION (2007)
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Dora Dias-Santagata et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Seibu Mochizuki et al.
LANCET (2007)
Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress
Meiko Hamai et al.
NEUROPHARMACOLOGY (2006)
Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2
Masaki Mogi et al.
HYPERTENSION (2006)
AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats
J Zhou et al.
STROKE (2006)
Cerebral vascular effects of angiotensin II: new insights from genetic models
FM Faraci et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
Brain angiotensin II: New developments, unanswered questions and therapeutic opportunities
JM Saavedra
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT(2) receptor expression
M Okumura et al.
HYPERTENSION (2005)
Oxidative stress signalling in Alzheimer's disease
XW Zhu et al.
BRAIN RESEARCH (2004)
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation
M Iwai et al.
CIRCULATION (2004)
Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats
H Ando et al.
STROKE (2004)
Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals
K Kazama et al.
CIRCULATION RESEARCH (2004)
Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics
RL Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The prevention of dementia with antihypertensive treatment
F Forette et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Potential for antihypertensive treatment with an AT1-receptor blocker to reduce dementia in the elderly
P Trenkwalder
JOURNAL OF HUMAN HYPERTENSION (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats
H Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)